Abstract
Aim: This study investigates whether the post intravitreal injection intraocular pressure (IOP) spike is modifiable with the use of prophylactic apraclonidine and dorzolomide. Methods: The study design was a prospective, randomised controlled trial. 80 eyes undergoing intravitreal injection of anti-VEGF agent were studied. A control group (n = 42) received no IOP lowering drops, and a study group (n = 38) received guttae apraclonidine and dorzolamide 30 to 40 minutes before the intravitreal injection. IOP measurements were taken in both groups using the Perkins tonometer at baseline, immediately before and after the injection, 5 minutes post-injection, and 15 minutes post-injection. Results: Mean IOP immediately post injection in the study group was 26.71 mmHg, and in the control group was 32.73. The main outcome measure was the area under the curve (AUC)—reflecting the trend of IOP post injection. The AUC was lower in the study group compared to the control group (Mann-Whitney U test, p = 0.046). Conclusions: The use of prophylactic apraclonidine and dorzolamide is effective in modifying the post-injection IOP spike. IOP lowering prophylaxis may be considered in patients with a high baseline IOP.
Highlights
The most exciting and innovative advance in ophthalmology in recent years is the introduction of intravitreal in-How to cite this paper: Pokrovskaya, O., Dooley, I., Babiker, S., Croghan, C., Hartnett, C. and Cullinane, A. (2015) The Effect of Intraocular Pressure Lowering Medications on the Pressure Spike Associated with Intravitreal Injection
The objective of our study is to determine whether the intraocular pressure (IOP) spike is modifiable by the prophylactic use of the combination of dorzolamide and apraclonidine 1%
Exclusion criteria included a history of ocular hypertension or glaucoma, and intravitreal injection of agents other than ranibizumab
Summary
The most exciting and innovative advance in ophthalmology in recent years is the introduction of intravitreal in-How to cite this paper: Pokrovskaya, O., Dooley, I., Babiker, S., Croghan, C., Hartnett, C. and Cullinane, A. (2015) The Effect of Intraocular Pressure Lowering Medications on the Pressure Spike Associated with Intravitreal Injection. (2015) The Effect of Intraocular Pressure Lowering Medications on the Pressure Spike Associated with Intravitreal Injection. These drugs have been shown to be sight-saving in a variety of retinal pathologies, including wet age-related macular degeneration and diabetic macular oedema [1]-[3]. One of the established side-effects of intravitreal injection is a temporary rise in the intraocular pressure (IOP) [4]-[6]. This has been attributed to volume expansion; the exact mechanism remains unclear [7] [8]. Routine IOP measurement before and after injection is generally not necessary, it should be considered in certain patients at risk of having a high IOP [9]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
